GC Cell shares plunge as US partner halts NK therapy development… Ativa to undergo restructuring
Predicted impact: Medium
Same NK drug halt and restructuring already reported; GC Cell drop was 9%.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.